Last Price
17.46
Today's Change
-0.15 (0.85%)
Day's Change
17.36 - 18.05
Trading Volume
210,949
Market Cap
481 Million
Shares Outstanding
27 Million
Avg Volume
240,353
Avg Price (50 Days)
14.90
Avg Price (200 Days)
10.32
PE Ratio
-25.30
EPS
-0.69
Earnings Announcement
05-Feb-2025
Previous Close
17.61
Open
17.71
Day's Range
17.36 - 18.05
Year Range
5.11 - 19.0
Trading Volume
210,949
1 Day Change
-0.85%
5 Day Change
-2.68%
1 Month Change
12.36%
3 Month Change
35.45%
6 Month Change
156.76%
Ytd Change
12.36%
1 Year Change
148.01%
3 Year Change
92.93%
5 Year Change
240.35%
10 Year Change
-43.31%
Max Change
-41.80%
No result.
Sector: Healthcare - Healthcare
Industry: Medical Devices
Description:
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite. It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.